Besides, HNSCC, esophageal squamous cell carcinoma and nasopharyngeal cancer (NPC) patients with a higher expression of CTLA-4 had a worse prognosis to those with lower CTLA-4 level (78–80). This evidence concerns the gene CTLA4 and esophageal squamous cell carcinoma.